Response to induction therapy:
Sixty-eight (68%) patients had rapid early response. MRD evaluation at day 15 showed >= 0.01% involvement in 37% and 63%(p=0.0009) of patients in standard and augmented groups, respectively. Similarly, the end of induction MRD was >=0.01% in 8% and 23% (p=0.03) of patients in standard and augmented groups, respectively.